Related Experiment Video
Updated: May 13, 2026

13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Prostate-specific antigen density: a better index of obesity-related PSA decrease in ostensibly healthy Korean men
Jae Heon Kim1, Seung Whan Doo, Won Jae Yang
1Department of Urology, Soonchunhyang University College of Medicine, Seoul, Korea.
Urology
|March 8, 2013
Summary
Prostate-specific antigen density (PSAD) shows a stronger negative correlation with obesity than prostate-specific antigen (PSA). This finding is significant for understanding prostate health in relation to body mass index (BMI).
Area of Science:
- Urology
- Endocrinology
- Public Health
Background:
- Obesity is a growing global health concern.
- The relationship between obesity and prostate health requires further investigation.
- Prostate-specific antigen (PSA) and prostate-specific antigen density (PSAD) are key biomarkers for prostate health.
Purpose of the Study:
- To compare the correlation between obesity and prostate-specific antigen density (PSAD) versus prostate-specific antigen (PSA).
- To assess the impact of Body Mass Index (BMI) on PSA and PSAD levels in Korean men.
Main Methods:
- A cohort of 2402 Korean men over 40 underwent prostate examinations.
- Data collected included anthropometric measurements, PSA levels, and transrectal ultrasound.
- Statistical analyses, including partial correlation and linear trend models, were used, adjusting for age.
Main Results:
- A significant negative correlation was observed between BMI and both PSA and PSAD.
- PSAD demonstrated a significant linear trend across all BMI groups.
- PSA showed a significant linear trend only in the obese BMI group (≥ 25 kg/m²).
Conclusions:
- Prostate-specific antigen density (PSAD) exhibits a more significant negative correlation with obesity than PSA.
- PSAD may be a more sensitive indicator of the relationship between obesity and prostate health compared to PSA.

